Drug Shortage Report for LOSARTAN HCT
| Report ID | 120603 |
| Drug Identification Number | 02388979 |
| Brand name | LOSARTAN HCT |
| Common or Proper name | LOSARTAN HCT |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | DORMANT |
| Active Ingredient(s) | LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE |
| Strength(s) | 100MG 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-08-17 |
| Actual start date | 2020-09-02 |
| Estimated end date | 2021-05-07 |
| Actual end date | 2021-05-07 |
| Shortage status | Resolved |
| Updated date | 2021-05-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2021-05-14 | French | Compare |
| v15 | 2021-05-14 | English | Compare |
| v14 | 2021-04-16 | French | Compare |
| v13 | 2021-04-16 | English | Compare |
| v12 | 2021-03-23 | French | Compare |
| v11 | 2021-03-23 | English | Compare |
| v10 | 2021-01-26 | French | Compare |
| v9 | 2021-01-26 | English | Compare |
| v8 | 2020-10-09 | French | Compare |
| v7 | 2020-10-09 | English | Compare |
| v6 | 2020-08-18 | English | Compare |
| v5 | 2020-08-04 | French | Compare |
| v4 | 2020-08-04 | English | Compare |
| v3 | 2020-08-02 | English | Compare |
| v2 | 2020-07-17 | French | Compare |
| v1 | 2020-07-17 | English | Compare |
Showing 1 to 16 of 16